Autoantibodies in multiple sclerosis patients before and during IFN-beta 1b treatment: are they correlated with the occurrence of autoimmune diseases?

Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research
E VerdunBetaferon Safety Trial (BEST) Study Group

Abstract

Autoimmune side effects, namely autoantibody (autoAb) occurrence and thyroid function alteration, have been described during interferon-beta (IFN-beta) treatment for multiple sclerosis (MS). AutoAb occurrence and autoimmune thyroid diseases are also frequently detected in MS patients free of any treatment. The aim of this study was to evaluate the relationship between IFN-beta 1b treatment, autoAb occurrence, and autoimmune diseases in MS. Thyroid and liver function and serum autoAb (antithyroid, antinuclear, anti-liver, anti-kidney microsomes, anti-smooth muscle and parietal cell antigens) occurrence were evaluated in 156 relapsing-remitting MS (RRMS) patients before and every 3 months after starting IFN-beta 1b treatment (8 MIU subcutaneously [s.c.] on alternate days). The probability of having liver or thyroid function alteration or autoAb occurrence was analyzed longitudinally with the generalized estimating equations (GEE) approach. At baseline, 16.1% of patients had autoAb. During treatment, autoAb occurred de novo in 7.2% of patients. GEE analysis showed that the probability of having autoAb at any time during IFN-beta 1b treatment did not change significantly compared with baseline. AutoAb occurring de novo rarely persi...Continue Reading

References

Dec 1, 1977·Clinical Endocrinology·W M TunbridgeP A Smith
Oct 1, 1992·Statistics in Medicine·S L Zeger, K Y Liang
Jun 1, 1991·Journal of Medical Virology·G FattovichA Ruol
Nov 1, 1991·The Journal of Experimental Medicine·F D FinkelmanW C Gause
Aug 1, 1991·Annals of Internal Medicine·L E RönnblomK E Oberg
Mar 16, 1990·JAMA : the Journal of the American Medical Association·M I SurksD H Solomon
Jan 1, 1990·Acta Neurologica Scandinavica·S SeyfertU Junghan
Feb 1, 1990·Italian Journal of Neurological Sciences·C IoppoliA Muratorio
Aug 1, 1988·European Journal of Cancer & Clinical Oncology·I S FentimanG F Bottazzo
Jul 1, 1989·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·W J MayetK H Meyer zum Büschenfelde
Mar 1, 1988·Neurology·J De Keyser
Jan 5, 1980·Lancet·W R Kiessling, K W Pflughaupt
Mar 1, 1983·Annals of Neurology·C M PoserW W Tourtellotte
Aug 1, 1982·Archives of Neurology·P Dore-DuffyR B Zurier
Feb 1, 1994·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·T Vial, J Descotes
Mar 1, 1995·Journal of Hepatology·P MarcellinJ P Benhamou
Feb 1, 1995·Neurology·S BarnedD H Mattson
Oct 1, 1995·Liver·C P Strassburg, M P Manns
Dec 20, 1995·Toxicology·T Vial, J Descotes
Jan 1, 1995·Duodecim; lääketieteellinen aikakauskirja·M PaneliusJ Ruutiainen
Dec 1, 1995·Neurology·O HeinzlefE Roullet
Jul 1, 1997·Journal of Endocrinological Investigation·N CustroA Notarbartolo
Jul 1, 1996·Multiple Sclerosis : Clinical and Laboratory Research·L DurelliB Bergamasco
Aug 26, 1998·Neurology·C PozzilliM Salvetti
Mar 4, 1999·Journal of the Neurological Sciences·L DurelliG Aimo
Sep 29, 1999·Journal of the Neurological Sciences·P AnnunziataG C Guazzi
Jun 10, 2000·Archives of Internal Medicine·P W LadensonH D Cohen
Sep 28, 2000·The New England Journal of Medicine·J H NoseworthyB G Weinshenker

❮ Previous
Next ❯

Citations

Jul 27, 2005·Journal of Neurology·Alasdair J ColesD Alastair Compston
Nov 7, 2009·Journal of Neuroimmune Pharmacology : the Official Journal of the Society on NeuroImmune Pharmacology·Ikuo Tsunoda, Robert S Fujinami
Dec 5, 2006·Current Opinion in Rheumatology·Frances A Y Borg, David A Isenberg
Feb 3, 2006·International Journal of Clinical Practice·S Alazemi, M A Campos
Dec 14, 2007·Neuro-degenerative Diseases·Joanne L Jones, Alasdair J Coles
Jun 19, 2013·PloS One·Andrew J SolomonRuth Whitham
Feb 20, 2009·American Journal of Epidemiology·Emily C SomersAndrew J Hall
Nov 19, 2004·Journal of Neurology·Gavin Giovannoni
Nov 19, 2004·Journal of Neurology·Anthony Traboulsee
Feb 28, 2006·Journal of Neurology·Olivier DeryckBénédicte Dubois
May 16, 2009·Journal of Neuroimmunology·Joerg-Patrick Stübgen
May 22, 2007·Journal of Neuroimmunology·Neeta GargBianca Weinstock-Guttman
May 12, 2007·Brain Pathology·Ikuo TsunodaRobert S Fujinami
Jan 3, 2008·Transplant International : Official Journal of the European Society for Organ Transplantation·Giada PietrosiBruno Gridelli
Oct 14, 2003·The American Journal of Medicine·Irit KrauseYehuda Shoenfeld
May 31, 2011·Journal of the Neurological Sciences·Joerg-Patrick Stübgen
Dec 7, 2014·Journal of the Neurological Sciences·Prudence TetteyIngrid A F van der Mei
May 27, 2015·Multiple Sclerosis and Related Disorders·Lynn ChouhfehBianca Weinstock-Guttman
Jun 6, 2007·Multiple Sclerosis : Clinical and Laboratory Research·G AlanogluS Kutluhan
Jan 18, 2012·Multiple Sclerosis : Clinical and Laboratory Research·G GiovannoniE Waubant
May 1, 2007·Multiple Sclerosis : Clinical and Laboratory Research·N GargM Ramanathan
Mar 13, 2018·Expert Opinion on Pharmacotherapy·Paulus S Rommer, Uwe K Zettl
Mar 5, 2019·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Babak SoleimaniDavid Hunt
Aug 12, 2009·Muscle & Nerve

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Thyroiditis

Autoimmune thyroiditis is an inflammatory disease of thyroid gland due to autoimmune responses leading to lymphocytic infiltration of the gland. It is characterized by the presence of circulating thyroid antigen-specific T-cells and thyroid autoantibodies. Discover the latest research on autoimmune thyroiditis here.

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.

Avian Influenza: Innate Immune Adjuvant (ASM)

Adjuvants systems that are added to vaccines against avian influenza have be explored to enhance the innate immune system response against the virus. Here is the latest research on avian influenza and the innate immune adjuvant.

Avian Influenza: Innate Immune Adjuvant

Adjuvants systems that are added to vaccines against avian influenza have be explored to enhance the innate immune system response against the virus. Here is the latest research on avian influenza and the innate immune adjuvant.